Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its